Peptisol

Filgrastim binds to cell surface receptors on hematopoietic cells in the bone marrow and stimulates neutrophil progenitor cell proliferation and differentiation

Hepatosol is a specialized nutrition formulated to meet the requirement for conditions such as chronic liver disease.

Hepatosol contains high energy and protein amount, completed with MCT (Medium Chain Triglycerides), BCAA (Branched-Chain Amino Acids), vitamins and minerals to restore/m...

Nephrisol is a specialized nutrition formulated to meet requirements for those with renal insufficiency, help delay CKD progression for patients on pre-dialysis stage.
Nephrisol contains low protein amount, completed with 9 essentials amino acids (High Biological Value Protein), and completed with 12 ...

Nephrisol-D is a specialized nutrition formulated to meet the requirements for those with renal insufficiency in dialysis stage, to replenish protein loss during dialysis and prevent malnutrition.

Nephrisol-D contains high protein amount, completed with 9 essentials amino acids (High B...

Nutrican is a special nutrition with high energy for patient with special nutrition needs to help prevent severe weight loss (cachexia) in chronic disease patient, such as cancer.

Nutrican contains high energy and high protein amount, completed with specific nutrients such as Omega 3 (...

Peptibren is a special nutrition with high energy for patient with special nutrition needs to improve brain health and prevent malnutrition.

Peptibren contains high protein amount, completed with specific nutrients such as Choline, Phosphatidylserine, and Nucleotide

Pulmosol is a specialized nutrition formulated to meet requirements for those with pulmonary disease.

Pulmosol contains high protein, low carbohydrate, BCAAs (Branched Chain Amino Acids), Omega–3,  Glutamine, Inulin, vitamins and minerals.

Efesa, is a long-acting Erythropoietin indicated for CKD-induced anemia in dialysis and non-dialysis patients. Efesa is a hybrid Fc of IgG4 and IgD that provides hinge flexibility and long serum half-life without causing toxicity to target cells. Global Phase 3 trial for non-dialysis indication is currentl...

Nimotuzumab binds with intermediate affinity and high specificity to the extracellular domain of EGFR and blocks the binding of the EGF to its receptor and inhibits tumor cell growth. The molecule induces cell lysis through ADCC mechanism. Nimotuzumab provides vaccinal effect that induce memory T-cell ...

Long-acting basal insulin analogue to treat Type I and II Diabetes Mellitus.

Indication: Chronic kidney diseases induced anemia (dialysis and non-dialysis)

Bevacizumab acts by selectively binding circulating VEGF, thereby inhibiting the binding of VEGF to its cell surface receptors. This inhibition leads to a reduction in microvascular growth of tumor blood vessels that limits the blood supply to tumor tissues.The indication is for Colorectal Cancer...

PT Kalbe Farma Tbk through its subsidiary PT Kalbe Genexine Biologicswith Shangai Henlius Biotech, Inc have entered into an exclusive license agreement for the development and commercialization of serplulimab injection in 12 Middle East and North African countries including Saudi Arabia, the United Arab Emirates, etc.